Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Leukemia
NCT00019227 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019227 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Leukemia |
| Official title | PHASE I/II STUDY OF TAC-EXPRESSING ADULT T-CELL LEUKEMIA (ATL) WITH YTTRIUM-90 (90Y)-RADIOLABELED HUMANIZED ANTI-TAC AND CALCIUM-DTPA |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Radiation Toxicity |
| Intervention type | Drug, Radiation |
| Interventions | pentetic acid calcium, yttrium Y 90 daclizumab |
| Start date | Oct 1, 1996 |
| Completion | Jul 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: